Logo image of XOS

XOS INC (XOS) Stock Fundamental Analysis

USA - NASDAQ:XOS - US98423B3069 - Common Stock

2.82 USD
+0.07 (+2.55%)
Last: 10/13/2025, 3:59:50 PM
Fundamental Rating

2

Taking everything into account, XOS scores 2 out of 10 in our fundamental rating. XOS was compared to 129 industry peers in the Machinery industry. XOS has a bad profitability rating. Also its financial health evaluation is rather negative. XOS is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

XOS had negative earnings in the past year.
XOS had a negative operating cash flow in the past year.
In the past 5 years XOS reported 4 times negative net income.
In the past 5 years XOS always reported negative operating cash flow.
XOS Yearly Net Income VS EBIT VS OCF VS FCFXOS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of -58.72%, XOS is doing worse than 90.70% of the companies in the same industry.
XOS's Return On Equity of -257.44% is on the low side compared to the rest of the industry. XOS is outperformed by 89.92% of its industry peers.
Industry RankSector Rank
ROA -58.72%
ROE -257.44%
ROIC N/A
ROA(3y)-56.86%
ROA(5y)-56.23%
ROE(3y)-127.49%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
XOS Yearly ROA, ROE, ROICXOS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200 -300 -400

1.3 Margins

With a Gross Margin value of 3.84%, XOS is not doing good in the industry: 91.47% of the companies in the same industry are doing better.
XOS's Gross Margin has declined in the last couple of years.
XOS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 3.84%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-24.85%
XOS Yearly Profit, Operating, Gross MarginsXOS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K

More info and screens

3

2. Health

2.1 Basic Checks

XOS does not have a ROIC to compare to the WACC, probably because it is not profitable.
XOS has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, XOS has less shares outstanding
Compared to 1 year ago, XOS has an improved debt to assets ratio.
XOS Yearly Shares OutstandingXOS Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
XOS Yearly Total Debt VS Total AssetsXOS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

Based on the Altman-Z score of -4.05, we must say that XOS is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of XOS (-4.05) is worse than 89.15% of its industry peers.
A Debt/Equity ratio of 0.86 indicates that XOS is somewhat dependend on debt financing.
XOS has a worse Debt to Equity ratio (0.86) than 75.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.86
Debt/FCF N/A
Altman-Z -4.05
ROIC/WACCN/A
WACC8.92%
XOS Yearly LT Debt VS Equity VS FCFXOS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

2.3 Liquidity

XOS has a Current Ratio of 2.22. This indicates that XOS is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.22, XOS is in line with its industry, outperforming 55.81% of the companies in the same industry.
XOS has a Quick Ratio of 1.18. This is a normal value and indicates that XOS is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.18, XOS perfoms like the industry average, outperforming 44.19% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.22
Quick Ratio 1.18
XOS Yearly Current Assets VS Current LiabilitesXOS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 27.68% over the past year.
Looking at the last year, XOS shows a very negative growth in Revenue. The Revenue has decreased by -19.19% in the last year.
XOS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 117.49% yearly.
EPS 1Y (TTM)27.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%10.78%
Revenue 1Y (TTM)-19.19%
Revenue growth 3Y122.95%
Revenue growth 5Y117.49%
Sales Q2Q%18.4%

3.2 Future

XOS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.76% yearly.
Based on estimates for the next years, XOS will show a quite strong growth in Revenue. The Revenue will grow by 9.03% on average per year.
EPS Next Y34.21%
EPS Next 2Y23.95%
EPS Next 3Y16.76%
EPS Next 5YN/A
Revenue Next Year-8.95%
Revenue Next 2Y7.69%
Revenue Next 3Y7.56%
Revenue Next 5Y9.03%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
XOS Yearly Revenue VS EstimatesXOS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20M 40M 60M 80M
XOS Yearly EPS VS EstimatesXOS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 -5 -10 -15

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

XOS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year XOS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
XOS Price Earnings VS Forward Price EarningsXOS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
XOS Per share dataXOS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4

4.3 Compensation for Growth

XOS's earnings are expected to grow with 16.76% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y23.95%
EPS Next 3Y16.76%

More info and screens

0

5. Dividend

5.1 Amount

XOS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

XOS INC

NASDAQ:XOS (10/13/2025, 3:59:50 PM)

2.82

+0.07 (+2.55%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)08-13 2025-08-13/amc
Earnings (Next)11-11 2025-11-11/amc
Inst Owners2.19%
Inst Owner Change-0.01%
Ins Owners36.13%
Ins Owner Change5.32%
Market Cap29.58M
Analysts80
Price Target6.63 (135.11%)
Short Float %11.56%
Short Ratio0.89
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.39%
Min EPS beat(2)-12.49%
Max EPS beat(2)15.27%
EPS beat(4)2
Avg EPS beat(4)-15.62%
Min EPS beat(4)-97.18%
Max EPS beat(4)31.92%
EPS beat(8)5
Avg EPS beat(8)0.74%
EPS beat(12)7
Avg EPS beat(12)-1.23%
EPS beat(16)9
Avg EPS beat(16)1.01%
Revenue beat(2)1
Avg Revenue beat(2)-1.89%
Min Revenue beat(2)-42.74%
Max Revenue beat(2)38.96%
Revenue beat(4)1
Avg Revenue beat(4)-17.84%
Min Revenue beat(4)-42.74%
Max Revenue beat(4)38.96%
Revenue beat(8)3
Avg Revenue beat(8)-6.3%
Revenue beat(12)4
Avg Revenue beat(12)-14.32%
Revenue beat(16)6
Avg Revenue beat(16)-13.65%
PT rev (1m)0%
PT rev (3m)8.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.54%
EPS NY rev (1m)2.93%
EPS NY rev (3m)2.93%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.02%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.87%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.57
P/FCF N/A
P/OCF N/A
P/B 1.61
P/tB 1.61
EV/EBITDA N/A
EPS(TTM)-5.46
EYN/A
EPS(NY)-2.83
Fwd EYN/A
FCF(TTM)-0.81
FCFYN/A
OCF(TTM)-0.79
OCFYN/A
SpS4.91
BVpS1.75
TBVpS1.75
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -58.72%
ROE -257.44%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 3.84%
FCFM N/A
ROA(3y)-56.86%
ROA(5y)-56.23%
ROE(3y)-127.49%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-24.85%
F-Score2
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 0.86
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2.82%
Cap/Sales 0.29%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.22
Quick Ratio 1.18
Altman-Z -4.05
F-Score2
WACC8.92%
ROIC/WACCN/A
Cap/Depr(3y)238.65%
Cap/Depr(5y)303.5%
Cap/Sales(3y)14.15%
Cap/Sales(5y)31.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%10.78%
EPS Next Y34.21%
EPS Next 2Y23.95%
EPS Next 3Y16.76%
EPS Next 5YN/A
Revenue 1Y (TTM)-19.19%
Revenue growth 3Y122.95%
Revenue growth 5Y117.49%
Sales Q2Q%18.4%
Revenue Next Year-8.95%
Revenue Next 2Y7.69%
Revenue Next 3Y7.56%
Revenue Next 5Y9.03%
EBIT growth 1Y11.84%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year60.4%
EBIT Next 3Y18.01%
EBIT Next 5Y10.17%
FCF growth 1Y90.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y89.86%
OCF growth 3YN/A
OCF growth 5YN/A